Methods and Compositions for Treatment of Attention Deficit Disorder
Ironshore Pharmaceuticals & Development, Inc.
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 22 of these applications claim priority to application 61/466,684, filed Mar 23, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,916,588 | Methods for Treatment of Attention Deficit Hyperactivity Disorder In force · Medium confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Medium confidence | ||
| US 8,927,010 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder In force · Medium confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Medium confidence | ||
| US 9,023,389 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder In force · Low confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Low confidence | ||
| US 9,028,868 | Methods and Compositions for Treatment of Attention Deficit Disorder In force · Medium confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Medium confidence | ||
| US 9,034,902 | Methods for Treatment of Attention Deficit Hyperactivity Disorder In force · Low confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Low confidence | ||
| US 9,119,809 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder In force · Medium confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Medium confidence | ||
| US 9,283,214 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder In force · Medium confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Medium confidence | ||
| US 9,289,394 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder In force · Medium confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Medium confidence | ||
| US 9,498,447 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder In force · Medium confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Medium confidence | ||
| US 9,511,032 | Compositions for Treatment of Attention Deficit Hyperactivity Disorder In force · Medium confidence | Ironshore Pharmaceuticals & Development, Inc. | In force | Medium confidence | ||
| 15 more patents in this group · Pro | ||||||
10 of 25 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 25.
22 of these are in force and held by Ironshore Pharmaceuticals & Development, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.